ID: ALA158985

Max Phase: Preclinical

Molecular Formula: C18H18N4S

Molecular Weight: 322.44

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(NCc2ccccc2)cc(SCc2ccccc2)n1

Standard InChI:  InChI=1S/C18H18N4S/c19-18-21-16(20-12-14-7-3-1-4-8-14)11-17(22-18)23-13-15-9-5-2-6-10-15/h1-11H,12-13H2,(H3,19,20,21,22)

Standard InChI Key:  IYMRMYAVCRXHQR-UHFFFAOYSA-N

Associated Targets(non-human)

DNA topoisomerase III 145 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 322.44Molecular Weight (Monoisotopic): 322.1252AlogP: 3.96#Rotatable Bonds: 6
Polar Surface Area: 63.83Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 7.27CX LogP: 4.53CX LogD: 4.30
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.53Np Likeness Score: -1.40

References

1. Trantolo DJ, Wright GE, Brown NC..  (1986)  Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines.,  29  (5): [PMID:3084785] [10.1021/jm00155a016]

Source